AN2 Therapeutics, Inc. ($ANTX)
Filing Information
| Accession Number | 0001193125-26-064174 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 23, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
115,000
Total Value
$0.00
P&L
+inf% (+$449,650.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Stock | โ | Feb 20, 2026 | Grant/Award | 38,000 | $0.00 | $0.00 | 118,363 | Direct | โ | View Details | |
Chief Financial Officer | Stock Option (right to buy) | Derivative | Feb 20, 2026 | Grant/Award | 77,000 | $0.00 | $0.00 | 77,000 | Direct | โ | View Details |